Form EFFECT Evaxion Biotech A/S
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 24, 2025 4:30 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evaxion shares preclinical data for CMV vaccine program EVX-V1
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Appoints CBIZ as Independent Registered Public Accounting Firm
- Pinwheel Reimagines the Home Landline for Today's Kids
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
